Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?

Literature DB >> 8456649

Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?

S J Adelstein¹.

Abstract

Mesh：

Substances：

Year: 1993 PMID： 8456649 DOI： 10.2214/ajr.160.4.8456649

Source DB: PubMed Journal: AJR Am J Roentgenol ISSN： 0361-803X Impact factor: 3.959

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Radioprobing of DNA: distribution of DNA breaks produced by decay of 125I incorporated into a triplex-forming oligonucleotide correlates with geometry of the triplex.

Authors: I G Panyutin; R D Neumann
Journal: Nucleic Acids Res Date: 1997-02-15 Impact factor: 16.971

2. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Authors: J Lewis; R Laforest; T Buettner; S Song; Y Fujibayashi; J Connett; M Welch
Journal: Proc Natl Acad Sci U S A Date: 2001-01-30 Impact factor: 11.205

3. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer.

Authors: Yunjun Guo; Jesse J Parry; Richard Laforest; Buck E Rogers; Carolyn J Anderson
Journal: J Nucl Med Date: 2013-07-19 Impact factor: 10.057

4. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases.

Authors: Georgios S Limouris; Achilles Chatziioannou; Dimitrios Kontogeorgakos; Dimitrios Mourikis; Maria Lyra; Panagiotis Dimitriou; Anastasia Stavraka; Athanassios Gouliamos; Lambros Vlahos
Journal: Eur J Nucl Med Mol Imaging Date: 2008-06-07 Impact factor: 9.236

Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?

1. Radioprobing of DNA: distribution of DNA breaks produced by decay of 125I incorporated into a triplex-forming oligonucleotide correlates with geometry of the triplex.

2. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

3. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer.

4. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases.

5. 111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.

6. Neuroendocrine tumors: a focus on liver metastatic lesions.

Review 7. Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters.